摘要
胰腺神经内分泌肿瘤(pancreatic neuroendocrine tumor,p—NETs)的发病率逐年提高。作为一种恶性肿瘤,它对人类健康的威胁越来越大。但和胰腺癌这类高度恶性的胰腺肿瘤相比,p—NETs生长速度较慢,早期诊断、早期治疗可达到较好的临床效果。然而目前对p-NETs的认识还有待提高。无论是临床诊断标记物,还是影像学检查方法,都缺乏精准诊断的检查靶点。在临床分期及疾病分级方面,同样存在很大争议。而作为最有效的治疗手段-手术治疗,在手术时机、手术方式、手术范围及术后药物治疗等方面均有待研究。本文针对上诉问题,结合我们的实践经验及研究结果进行简要论述。
Pancreatic neuroendocrine tumor (p-NET) is a kind of neoplasm originating from neuroendocrine cell of pancreas. The morbidity of p-NET increased 5 times in the past 40 years and threatened people's life. However, the key points of diagnosis and treatment for p-NET are still unclear. There were no special and easy blood tests or imaging scanning for p-NET. The TNM classification remains controversial. Surgery is the most effective method to cure p-NET. But we still need to clarify which is the best time or method for surgery. In this review, we try to answer above questions based on our experiences and studies.
作者
柯能文
刘续宝
Ke Nengwen Liu Xubao(Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China)
出处
《中华内分泌外科杂志》
CAS
2016年第6期441-445,共5页
Chinese Journal of Endocrine Surgery
关键词
胰腺
神经内分泌肿瘤
临床分级
Pancreas
Neuroendocrine tumor
TNM classification